Skip to main content
. 2016 Aug 29;19(2):242–251. doi: 10.1093/neuonc/now176

Table 3.

Comparison to prior studies investigating use of TMZ in LGG

Study # Patients Median F/U Response Rate (CR + PR) 3y PFS 3y OS
Brada et al14 30 3 y 10% 66% 82%
Quinn et al17 46 <1 y 61% NR NR
Hoang-Xuan et al16 60 1.2 y 17% NR NR
Kesari et al15 44 3 y 20% 57% 81%
UCSF TMZ 120 7.5 y 6% 58% 81%

F/U, follow-up; CR, complete response; PR, partial response. NR, not reported; UCSF, University of California, San Francisco.